Aliases for ERV3-1 Gene
- Endogenous Retrovirus Group 3, Member 1 2 3
- ERV3 3 4 6
- HERV-R_7q21.2 Provirus Ancestral Env Polyprotein 3 4
- Endogenous Retroviral Sequence 3 2 3
- ERV3-1 Envelope Protein 3 4
- HERV-R Envelope Protein 3 4
- ERV-3 Envelope Protein 3 4
- ERV-R Envelope Protein 3 4
- Endogenous Retroviral Sequence 3 (Includes Zinc Finger Protein H-Plk/HPF9) 2
External Ids for ERV3-1 Gene
Previous HGNC Symbols for ERV3-1 Gene
Previous GeneCards Identifiers for ERV3-1 Gene
The human genome includes many retroelements including the human endogenous retroviruses (HERVs). ERV3, one of the most studied HERVs, is thought to have integrated 30 to 40 million years ago and is present in higher primates with the exception of gorillas. Taken together, the observation of genome conservation, the detection of transcript expression, and the presence of conserved ORFs is circumstantial evidence for a functional role. A functional role is also suggested by the observation that downregulation of ERV3 is reported in choriocarcinoma. [provided by RefSeq, Jul 2008]
GeneCards Summary for ERV3-1 Gene
ERV3-1 (Endogenous Retrovirus Group 3, Member 1) is a Protein Coding gene. Diseases associated with ERV3-1 include choriocarcinoma.
UniProtKB/Swiss-Prot for ERV3-1 Gene
Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its fusogenic properties. It can inhibit cell growth through decrease expression of cyclin B1 and increased expression of p21 in vitro.
SU mediates receptor recognition.
TM anchors the envelope heterodimer to the viral membrane through one transmembrane domain. The other hydrophobic domain, called fusion peptide, mediates fusion of the viral membrane with the target cell membrane (By similarity).